KEGG: yli:YALI0F29491g
STRING: 4952.XP_506016.1
Based on available data and general principles for mitochondrial membrane protein expression, the following systems can be considered:
For IML2 specifically, E. coli expression with N-terminal His-tagging has been documented as successful, with protein stored in Tris/PBS-based buffer containing 6% Trehalose at pH 8.0 . Alternative expression in Y. lipolytica itself could provide native-like protein but would require adaptation of the multi-copy integration system described for steroidogenic proteins .
Successful purification of IML2 requires strategies tailored to membrane proteins:
Affinity chromatography using the N-terminal His-tag provides efficient initial capture (immobilized metal affinity chromatography)
Solubilization requires careful detergent selection—mild detergents like DDM (n-dodecyl-β-D-maltoside) or LDAO (lauryldimethylamine oxide) are recommended for maintaining native structure
Buffer optimization should include:
Size exclusion chromatography as a second purification step removes aggregates and improves homogeneity
Avoid repeated freeze-thaw cycles; store working aliquots at 4°C for up to one week
For membrane reconstitution, addition of phosphatidylcholine may help restore native activity (400-500 molecules per protein complex has proven effective for other Y. lipolytica mitochondrial proteins)
Reconstitution into nanodiscs or liposomes may improve stability for functional and structural studies
A systematic experimental strategy would include:
Genetic approaches:
Localization studies:
Fusion with fluorescent proteins for in vivo localization
Immunogold electron microscopy for precise submitochondrial localization
Subcellular fractionation and Western blotting
Interaction studies:
Affinity purification-mass spectrometry to identify binding partners
Co-immunoprecipitation with antibodies against IML2
Crosslinking followed by MS identification
Functional analysis:
Assess mitochondrial morphology in knockout/knockdown cells
Measure respiratory chain activity in IML2-deficient cells
Analyze mitochondrial membrane potential using fluorescent dyes
Examine mtDNA stability and nucleoid organization
This multi-faceted approach follows experimental design principles that systematically test hypotheses about IML2 function while controlling for variables that might influence results .
Several complementary techniques can reveal IML2's interaction network:
| Technique | Application for IML2 | Controls | Advantages |
|---|---|---|---|
| Affinity purification-MS | Comprehensive identification of interaction partners | Non-specific binding controls (empty vector) | Identifies complete interactome |
| Co-immunoprecipitation | Validation of specific interactions | IgG control, input controls | Confirms interactions under native conditions |
| Proximity labeling (BioID/APEX) | In vivo detection of proximal proteins | Non-targeting construct controls | Identifies transient interactions |
| Crosslinking-MS | Mapping interaction interfaces | Non-crosslinked samples | Provides structural information |
| Yeast two-hybrid | Screening for direct interactions | Empty vector, known interactors | High-throughput screening capability |
| Split fluorescent protein systems | In vivo visualization of interactions | Negative control protein pairs | Direct visualization in native environment |
For membrane proteins like IML2, techniques that maintain the native membrane environment (proximity labeling, crosslinking) may provide more reliable results than those requiring solubilization. The dual approach of comprehensive screening followed by targeted validation has proven successful for characterizing other mitochondrial membrane protein complexes .
Researchers face several significant challenges when working with IML2 and similar proteins:
Expression difficulties: Membrane proteins often exhibit toxicity to host cells when overexpressed, necessitating careful regulation of expression levels
Proper folding: Ensuring correct insertion into membranes in heterologous systems requires optimization of expression conditions
Solubilization issues: Maintaining native conformation during extraction from membranes demands extensive detergent screening
Low yields: Membrane proteins typically produce lower yields than soluble proteins, requiring scale-up of production
Purification complexity: Multiple chromatography steps may be needed to achieve high purity while maintaining activity
Functional reconstitution: Restoring native activity often requires incorporation into artificial membranes or addition of specific lipids
Structural analysis limitations: Crystallization of membrane proteins for structural studies presents significant technical hurdles
Species-specific factors: Y. lipolytica has unique mitochondrial characteristics that may not be replicated in heterologous systems
These challenges necessitate careful optimization at each step of the experimental workflow, from gene design through functional analysis.
A systematic mutagenesis approach would include:
Sequence analysis: Identify conserved residues through multiple sequence alignment with orthologs from related species
Domain mapping: Generate truncation mutants to identify functional domains (transmembrane regions, interaction surfaces)
Targeted mutations:
Convert key hydrophobic residues in transmembrane domains to assess membrane integration
Mutate potential phosphorylation sites to investigate regulation
Alter conserved charged residues that may participate in protein-protein interactions
Complementation testing: Introduce mutated constructs into IML2-deficient strains to assess functional rescue
Expression verification: Confirm expression of mutant proteins by Western blotting
Localization analysis: Ensure proper targeting of mutants to mitochondria using fluorescent protein fusions
The two-step approach for constructing recombinant strains described for Y. lipolytica provides an effective framework for introducing and testing multiple mutations. This approach has successfully identified functionally important amino acids in other mitochondrial proteins from this organism .
Quality assessment of recombinant IML2 should include multiple complementary techniques:
Gel filtration chromatography: Evaluates homogeneity and oligomeric state; properly folded protein should elute as a symmetrical peak at the expected molecular weight
Circular dichroism (CD) spectroscopy: Assesses secondary structure content; membrane proteins typically show characteristic α-helical signatures
Fluorescence-detected size exclusion chromatography (FSEC): Particularly valuable for membrane proteins, monitors protein quality without the need for purification
Thermal shift assays: Properly folded proteins typically exhibit cooperative unfolding transitions
Limited proteolysis: Well-folded proteins show resistance to proteolytic degradation except at exposed flexible regions
Functional assays: If specific activity is known, activity measurements provide the ultimate validation of proper folding
Binding assays: Interaction with known binding partners confirms functional conformation
These approaches should be used in combination to provide a comprehensive assessment of protein quality before proceeding to functional or structural studies.
A comprehensive experimental strategy would include:
Genetic manipulation in Y. lipolytica:
Functional characterization:
Measure respiratory chain activity using oxygen consumption rate measurements
Assess mitochondrial membrane potential using fluorescent dyes (JC-1, TMRM)
Quantify reactive oxygen species production using specific probes
Analyze mitochondrial morphology using fluorescence and electron microscopy
Measure mtDNA stability, copy number, and nucleoid organization
Drug response studies:
Comparative analysis:
Extend findings to mammalian models through complementation studies
Express human orthologs in Y. lipolytica IML2 deletion strains
Compare phenotypes with known mitochondrial disease models
This approach leverages Y. lipolytica's advantages as a model system while providing translational relevance to human mitochondrial disorders .
Identifying authentic interactions within membrane environments requires specialized approaches:
Proximity-based labeling: BioID or APEX2 fused to IML2 allows in vivo biotinylation of neighboring proteins, followed by streptavidin pulldown and mass spectrometry analysis
Crosslinking mass spectrometry: Chemical crosslinkers (DSS, BS3) or photo-crosslinkers stabilize interactions before extraction from membranes
Co-purification under native conditions: Mild detergent solubilization followed by affinity purification can maintain intact complexes
Blue native PAGE: Separates intact membrane protein complexes while preserving native interactions
Förster resonance energy transfer (FRET): When combined with appropriate fluorophore pairs, allows detection of interactions in living cells
Split-protein complementation assays: Systems like split-GFP or split-luciferase can validate specific interactions in vivo
Co-localization studies: Super-resolution microscopy can identify proteins that co-localize with IML2 at nanometer resolution
Validation should include reciprocal pulldowns, competition assays, and mutation of predicted interaction surfaces to confirm specificity . The established methods for purification of mitochondrial complexes from Y. lipolytica provide a useful framework for these studies .
Structural analysis of membrane proteins like IML2 presents unique challenges requiring specialized techniques:
The success of cryo-EM for other Y. lipolytica mitochondrial complexes suggests this approach may be particularly promising for IML2, especially if it forms part of a larger complex . A hybrid approach combining multiple techniques will likely provide the most comprehensive structural information.
Rigorous experimental design for IML2 studies should include these controls:
Expression controls:
Empty vector transfections/transformations
Unrelated membrane protein expressed under identical conditions
Wild-type IML2 as positive control for mutational studies
Purification controls:
Mock purification from cells not expressing IML2
Purification of a well-characterized protein using identical protocols
Functional controls:
Complementation with wild-type IML2 in knockout strains
Inactive mutants (identified through preliminary studies)
Temperature-sensitive variants if available
Interaction controls:
Competition with excess unlabeled protein
Use of scrambled peptides for peptide interaction studies
IgG or pre-immune serum controls for immunoprecipitation
Localization controls:
Co-staining with established mitochondrial markers
Fractionation quality controls (markers for different compartments)
These controls address the experimental design principles outlined for rigorous research , including accounting for variables that might influence results and ensuring specificity of observed effects.